Tizanidine Hcl Capsule
Product Images NDC 80425-0090

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hcl (NDC 80425-0090). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1

A line graph showing plasma concentration of Tizanidine HCL (ng/mL) over time (hours) from dosing. Four curves represent 2 x 4 mg Tizanidine tablets and capsules both with and without food, tracking concentration changes from 0 to 26 hours post-dose.*

FDA Label Image

Fig 2

A line graph depicting improvement in Ashworth Score over time (hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis shows improvement scores, with negative scores indicating improvement. Time points at 0, 1, 2, 3, and 6 hours post-dose are plotted with error bars for each treatment group.*

FDA Label Image

Fig 3

A line graph comparing the improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo groups over three time points: End of Titration (Study Week 3), End of Maintenance (Study Week 7), and Endpoint (Last Observation Carried Forward). The vertical axis represents improvement values from -6 to 2, with tizanidine showing greater improvement (lower scores) and placebo showing little to no improvement, along with error bars indicating variability.*

FDA Label Image

Structure

Chemical structure of Tizanidine HCL showing its molecular framework with chlorine, sulfur, nitrogen atoms, and hydrochloride component.*

FDA Label Image

Tizanidine HCl 4mg Cap Qty 60 Ndc 80425 0090

Tizanidine HCL 4 mg capsule packaging label from Advanced Rx of Tennessee, LLC. The label includes the proprietary and generic names, NDC 80425-0090-01, source NDC 50742-0225-15, lot number T473021 with expiration 7/30/2021, and storage conditions of 20°-25°C (68°-77°F). The label also cautions against unauthorized drug transfer and lists Ingenus Pharmac as part of the labeling.*

FDA Label Image

Tizanidine HCl 4mg Cap Qty 90 Ndc 80425 0090

Label for Tizanidine HCL 4 mg capsules from Advanced Rx of Tennessee, LLC. The label includes the product name, strength, NDC number 80425-0090-02, lot number, expiration date, source NDC 50742-0223-15, and storage instructions (20°-25°C). Also features a barcode and a caution statement regarding federal law on drug transfer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.